About Rhythm Biosciences
Rhythm Biosciences is an innovative Australian, publicly listed medical diagnostics company, with a focus on delivering simple, affordable blood tests for the accurate detection of cancers, providing physicians with accurate and reliable diagnostic tools.
Early detection is critical to improving patient outcomes and reducing the global burden of cancer.
ColoSTAT®, Rhythm Bioscience’s first simple blood-base cancer test, designed for the early detection of colorectal cancer, has been developed initially as an alternative screening test for individuals unable to or are unwilling to use currently available screening modalities.
Rhythm Biosciences is committed to working with likeminded global partners to achieve commercialisation and distribution of these simple solutions.
Our Mission
Rhythm Biosciences Timeline
CSIRO Research and Development
Rhythm Bio Lists on the ASX
Development Program Commences
Clinical Trial Program Commences
ISO Certification
Patents Secured in 21 Countries
Global Manufacturer Appointed
Clinical Trial Complete (RHY-001)
CE Mark Granted for ColoSTAT®
ColoSTAT® Authorised for Sale in New Zealand
UKCA Mark Granted and Strategic Partnership with LINK Medical Solutions
RHY001 Study - Submit Publication
International Market Entry
Pipeline Activities - Other Cancers
TGA Submission
Pipeline
Leveraging the proprietary immunoassay, developed for our ColoSTAT® blood test, Rhythm Biosciences is investigating the feasibility of using this technology to establish diagnostic tests for detection of other cancer types.
Cancer Target
Collaborator
Theoretical Analysis of Biomarker Potential
Serum and Algorithm Analysis
Risk Analysis ➝ Enter Stage 2
Breast
Agilex Biolabs P/L
Lung
Baker Institute
Stomach
Nexomics
Cervix
TBD
Pancreas
TBD
About us:
Contact
Rhythm Biosciences
Bio21 Institute
30 Flemington Road
Parkville VIC 3010
Australia
